Target intelligence / Profile preview

Cysteine desulfurase (NFS1) (NFS1)

Target
NFS1
Molecular classification
Enzyme, Sulfurtransferase, Lyase, Pyridoxal-phosphate-dependent enzyme
01

Overview

Cysteine desulfurase (NFS1) is a critical pyridoxal-phosphate-dependent enzyme that catalyzes the conversion of L-cysteine to L-alanine and a sulfur-containing persulfide intermediate [11, 19]. This enzyme serves as the primary sulfur donor for the biogenesis of iron-sulfur (Fe-S) clusters, which are indispensable cofactors for dozens of proteins involved in cellular respiration, DNA repair, and iron homeostasis [6, 17]. In the context of oncology, NFS1 is recognized as a key therapeutic target because its overexpression in certain cancers, particularly lung adenocarcinoma and gastric cancer, protects cells from oxidative stress and ferroptosis by maintaining Fe-S cluster integrity in high-oxygen environments [4, 10, 20]. Therapeutic strategies currently under investigation include the use of selective small-molecule inhibitors like Compound 53 and inhibitory decoy substrates such as D-cysteine to sensitize tumors to ferroptotic cell death [1, 5, 13]. However, as NFS1 is a vital housekeeping enzyme, developing these therapies requires careful management of potential toxicities associated with the disruption of essential mitochondrial functions in healthy tissues [6, 20].

Other names
NFS1IscS homologNitrogen fixation 1Cysteine desulfurylaseNifS homolog
02

Mechanism of action

Selective inhibition of enzymatic activity or acting as a decoy substrate to disrupt sulfur mobilization, thereby impairing iron-sulfur cluster biogenesis and inducing ferroptosis [1, 2, 20].

03

Biological functions

Iron-sulfur cluster biogenesisFerroptosis suppressiontRNA thiolationMolybdenum cofactor biosynthesisCellular iron homeostasisMitochondrial metabolism
04

Disease associations

CancerLung adenocarcinomaGastric cancerTriple-negative breast cancerInfantile mitochondrial complex II/III deficiencyNeurodegenerative disease
05

Safety considerations

Potential systemic toxicity due to essential mitochondrial housekeeping rolesRisk of mitochondrial dysfunction and complex II/III deficiencyImpairment of DNA repair and genome integrity
06

Interacting drugs

Compound 53 (PubChem CID 136847320)

3 more in the full profile.

07

Biomarkers

NFS1 expression (mRNA/protein)SLC7A11 (xCT) expressionAconitase activityIntracellular iron levels

Beyond the preview

Go deeper on Cysteine desulfurase (NFS1) (NFS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cysteine desulfurase (NFS1) (NFS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call